Equine Research Projects Get Racing Commission Approval

Six equine research projects totaling nearly $400,000 over a two-year period have been approved by the Kentucky Horse Racing Commission.

All of the research, approved by the commission Jan. 5, will be conducted by the Kentucky Equine Initiative at the University of Kentucky. Approval by the commission came on a recommendation from the KHRC's Equine Drug Research Council, which approved the projects during a meeting that preceded the commission meeting.

While the commission approved the research grants with little or no discussion, there was considerable discussion about the viability of some of the projects and the procedures that would be used during the drug research council's consideration of the proposals.

The commission approved the grants with the caveat that a portion of any profits derived by the University of Kentucky from the research be directed toward equine research. The grants are the result of work by an EDRC research advisory group that began in May 2009. There were 13 proposals submitted before the Nov. 1 deadline, with the advisory group then performing independent reviews of the proposals. After additional consideration, the proposals were given a preliminary ranking and then submitted to external reviewers with expertise within the respective field to be researched.

Summaries of the research proposals and principal investigators for the projects, totaling $386,587 over two years, are:

  • Comparison of in vitro antiviral activity of herpesvirus DNA polymerase inhibitors against neuropathogenic and non-neuropathogenic strains of equine herpesvirus-1: Udeni Balasuriya
  • Seroprevalence of Lawsonia intracellularis in Central Kentucky Thoroughbred weanlings: David W. Horohov
  • Changes in gastrointestinal flora in response to antibiotic therapy and dietary intervention: Laurie Lawrence
  • Safety and anti-inflammatory efficacy of glucocorticoids for intra-articular therapy in racehorses: James N. McLeod
  • Methods to suppress estrus in race mares: Edward L. Squires
  • Deuterated internal standards for equine therapeutic medication regulation: Thomas Tobin

During the equine drug research council's deliberation, concern was expressed over how much control the racing commission and council would have over ensuring that the research was being conducted in accordance with the proposals. Some questioned whether the funds allocated to the projects could be refunded if a funded proposal was not concluded to the satisfaction of the drug council and racing commission.

Nancy Cox, MS, PhD, of the UK Equine Initiative, explained that there were sufficient reporting and monitoring mechanisms in place to see that the projects were on schedule as the research took place. She said there would be no point in a researcher failing to fulfill the terms of the project since it would potentially affect their ability to obtain future grants.

Cox also allayed concerns expressed by drug research council members Rogers Beasley and Gary Lavin, VMD, about some of the proposals, particularly the research that would be conducted by Tobin on internal standards for equine therapeutic medication regulation.

In response to Beasley's questions about who would profit from the results of the research, Cox said the university had a standardized format for licensing of intellectual property such as equine research and that a competitive bidding process would take place. She also said there was a standard formula for distribution from any royalties as a result of the research.

Lavin questioned whether the type of research proposed under Tobin's project had not already been conducted. Tobin responded that despite the prevalence of equine drug research, standardized methods of conducting the research had not been researched.

(Originally published at BloodHorse.com.)

About the Author

Ron Mitchell/The Horse

Ron Mitchell is Online Managing Editor for The Blood-Horse magazine. A Lexington native, Mitchell joined The Blood-Horse after serving in editorial capacities with The Thoroughbred Record and Thoroughbred Times, specializing in business and auction aspects of the industry, and was editor-in-chief of the award-winning Horsemen’s Journal. As online managing editor, Mitchell works closely with The Blood-Horse news editor and other departments to make sure the website content is the most thorough and accurate source for all Thoroughbred news, results, videos, and data.

Stay on top of the most recent Horse Health news with FREE weekly newsletters from TheHorse.com. Learn More

Free Newsletters

Sign up for the latest in:

From our partners